Review ARTICLES

REVIEW ARTICLES: Peer Reviewed

1.  Kumar G, Thakur V, Sardana S, Tiwari V*, Sharma D, Kumar A. Contemporary trends in targeted protein degradation for neurodegenerative diseases. European Journal of Medicinal Chemistry. 2025 Aug 29:118110. (Impact Factor-5.9)

2. Verma N, Chouhan D, Meghana A, Tiwari V*. Molecular Chaperones to Pain Modulators: Heat Shock Proteins the Emerging Players in Chronic Pain Management. Neuropharmacology. 2024 Dec 10:110263. (Impact Factor – 4.7)

3.  Babu N, Gadepalli A, Akhilesh, Sharma D, Singh A, Chouhan D, Agrawal A, Tiwari V*. TLR-4: a promising target for chemotherapy-induced peripheral neuropathy. Molecular Biology Reports. October 2024 (Impact Factor – 2.6)

4. Allani, M., Akhilesh and Tiwari, V., 2024. Caspase‐driven cancer therapies: Navigating the bridge between lab discoveries and clinical applications. Cell Biochemistry and Function, 42(2), p.e3944. (Impact Factor – 2.8)

5.   Dobhal S, Nandave M, Tiwari V, Singh MF. Unveiling the potential of Cepharanthine from plant to patient-A comprehensive review of phytochemistry, pharmacology and clinical investigations. Journal of Biologically Active Products from Nature. 2024 Jan 2;14(1):1-34. (Impact Factor – 1.20)

6. Uniyal, A., Tiwari, V., Tsukamoto, T., Dong, X., Guan, Y. and Raja, S.N., 2023. Targeting sensory neuron GPCRs for peripheral neuropathic pain. Trends in Pharmacological Sciences. (Impact Factor – 17.63)

7. Nigam, M., Mishra, A.P., Deb, V.K., Dimri, D.B., Tiwari, V., Bungau, S.G., Bungau, A.F. and Radu, A.F., 2023. Evaluation of the association of chronic inflammation and cancer: Insights and implications. Biomedicine & Pharmacotherapy, 164, p.115015 (Impact Factor- 7.419)

8. Modi A, Pandey P, Akhilesh, Uniyal A, Chouhan D, Agrawal S, Allani M, Singh AK, Kumar S, Tiwari V*. Disentangling the enigmatic role of ephrin signaling in chronic pain: Moving towards future anti-pain therapeutics. Life Sciences. 2022 In-press (Impact Factor- 6.780) ISSN: 0024-3205. *CORRESPONDING AUTHOR

9. Naren, P, Cholkar, A, Kamble, S, Samim, K.S., Srivastava, S, Madan, Mehra, N, Tiwari, V, Singh, S.B. and Khatri, D.K. Pathological and Therapeutic Advances in Parkinson’s Disease: Mitochondria in the Interplay. Journal of Alzheimer's Disease, (Preprint), pp.1-30. 2022. (Impact factor: 9.423). ISSN: 1939-0041.

10. Shah, S, Famta, P, Tiwari, V, Kotha, A.K, Kashikar, R, Chougule, M.B, Chung, Y.., Steinmetz, N.F, Uddin, M, Singh, S.B. and Srivastava, S. Instigation of the epoch of nanovaccines in cancer immunotherapy. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, pp1870. 2022. (Impact factor: 9.423). ISSN: 1939-0041.

11. Roy T, Uniyal A, Akhilesh, Tiwari V*. Multifactorial Pathways in Burn Injury-induced Chronic Pain: Novel Targets and their Pharmacological Modulation. Molecular biology reports. 2022. (Impact factor: 2.6). ISSN: 0024-3205. *CORRESPONDING AUTHOR

12. Rani M, Uniyal A, Akhilesh, Tiwari V*. Decrypting the Cellular and Molecular Intricacies Associated with COVID-19-induced Chronic Pain. Metabolic brain disease. 2022. (Impact Factor- 3.584) ISSN: 1573-7365. *CORRESPONDING AUTHOR

13.  Akhilesh, Uniyal A, Gadepalli A, Tiwari V, Allani M, Chouhan D, Ummadisetty O, Verma N, Tiwari V*. Unlocking the potential of TRPV1 based siRNA therapeutics for the treatment of chemotherapy-induced neuropathic pain. Life Sciences. 2022 Jan 1; 288:120187. (Impact Factor- 5.037) ISSN: 0024-3205. *CORRESPONDING AUTHOR

14.  Naik GG, Uniyal A, Chouhan D, Tiwari V, Sahu AN. Natural Products and some semi- synthetic analogues as potential TRPV1 Ligands for attenuating Neuropathic pain. Current pharmaceutical biotechnology 2022. (Impact Factor- 2.6) ISSN: 1873-4316.

15.  Gadepalli A, Akhilesh, Uniyal A, Modi A, Chouhan D, Ummadisetty O, Khanna S, Solanki S, Allani M, Tiwari V*. Multifarious Targets and Recent Developments in the Therapeutics for the Management of Bone Cancer Pain. ACS chemical neuroscience. 2021 Nov 1;12(22):4195-208. ACS Chem Neurosci. 2021 Aug 18;12(16):2956-2963. (Impact Factor- 4.418) ISSN: 1948-7193 *CORRESPONDING AUTHOR

16.  Uniyal A, Tiwari V, Rani M, Tiwari V*. Immune-microbiome interplay and its implications in neurodegenerative disorders. Metabolic Brain Disease. 2021 Aug 6:1-21. (Impact Factor- 3.584) ISSN: 1573-7365. *CORRESPONDING AUTHOR

17. Uniyal A, Thakur V, Rani M, Tiwari V, Akhilesh, Gadepalli A, Ummadisetty O, Modi A, Tiwari V*. Kinesin Nanomotors Mediated Trafficking of NMDA-Loaded Cargo as A Novel Target in Chronic Pain. ACS Chem Neurosci. 2021 Aug 18;12(16):2956-2963. (Impact Factor- 4.418) ISSN: 1948-7193 *CORRESPONDING AUTHOR

18.  Singh RS, Singh A, Kaur H, Batra G, Sarma P, Kaur H, Bhattacharyya A, Sharma AR, Kumar S, Upadhyay S, Tiwari V, Avti P, Prakash A, Medhi B. Promising traditional Indian medicinal plants for the management of novel Coronavirus disease: A systematic review. Phytother Res 2021 Jun 16. doi: 10.1002/ptr.7150. (Impact Factor- 4.087) ISSN: 1099-1573.

19.  Thakur V, Uniyal A, Tiwari V*. A comprehensive review on pharmacology of efflux pumps and their inhibitors in antibiotic resistance. Eur J Pharmacol. 2021 May 5; 903:174151. (Impact Factor- 4.432) ISSN: 0014-2999 *CORRESPONDING AUTHOR

20.  Tiwari V, Venugopala KN, Deb PK. Perspectives of In silico, In vitro and Integrated ADMET Profiling in the Drug Discovery and Development. Current Drug Metabolism 2021. (Impact Factor – 3.731)

21. Borah P, Deb PK, Venugopala KN, Al-Shar'i NA, Singh V, Deka S, Srivastava A, Tiwari V, Mailavaram RP. Tuberculosis: An Update on Pathophysiology, Molecular Mechanisms of Drug Resistance,Newer Anti-TB Drugs, Treatment Regimens and Host-Directed Therapies. Current Topics in Medicinal Chemistry 2021;21(6):547-570. (Impact Factor- 3.295) ISSN: 1873-4294

22. Dagamajalu S, Rex DAB, Gopalakrishnan L, Karthikkeyan G, Gurtoo S, Modi PK, Mohanty V, Mujeeburahiman M, Soman S, Raju R, Tiwari V, Prasad TSK. A network map of endothelin mediated signaling pathway. Journal of Cell Communication and Signaling 2021 Jun;15(2):277-282. (Impact Factor- 5.782) ISSN: 1873-9601

23. Shaw S, Uniyal A, Gadepalli A, Tiwari V, Belinskaia DA, Shestakova NN, Venugopala KN, Deb PK, Tiwari V*. Adenosine receptor signalling: Probing the potential pathways for the ministration of neuropathic pain. European Journal of Pharmacology, 2020 Oct 2;889:173619. (Impact Factor- 4.432) ISSN: 0014-2999 *CORRESPONDING AUTHOR

24. Chouhan D, Uniyal A, Gadepalli A, - A, Tiwari V, Agrawal S, Roy TK, Shaw S, Purohit N, Tiwari V*. Probing the Manipulated Neurochemical Drive in Alcohol Addiction and Novel Therapeutic Advancements. ACS Chem Neurosci. 2020, May 6;11(9):1210-1217. (Impact Factor- 4.418) ISSN: 1948-7193 *CORRESPONDING AUTHOR

25. Uniyal A, Gadepalli A, Akhilesh, Tiwari V*. Underpinning the Neurobiological Intricacies Associated with Opioid Tolerance. ACS Chem Neurosci. 2020, Mar 18;11(6):830-839. (Impact Factor- 4.418) ISSN: 1948-7193 *CORRESPONDING AUTHOR

26. Bidve P, Prajapati N, Kalia K, Tekade R, Tiwari V*. Emerging Role of Nanomedicine in the Treatment of Neuropathic Pain. J Drug Target. 2020 Jan;28(1):11-22. (Impact Factor- 3.121). ISSN: 1029-2330 *CORRESPONDING AUTHOR

27. P.A S, Sharma D, Sharma M, Vaidya S, Sharma K, Kalia K, Tao YX, Shard A, Tiwari V*. Kinesins: Motor Proteins as Novel Target for the Treatment of Chronic Pain. Molecular Neurobiology 2019 Jun;56(6):3854-3864. (Impact Factor- 5.590). ISSN: 1559-1182 *CORRESPONDING AUTHOR

28. Sharma D, Verma S, Vaidya S, Kalia K, Tiwari V*. Recent Updates on GLP-1 Agonists: Current Advancements & Challenges. Biomedicine & Pharmacotherapy 2018 Dec; 108:952-962 (Impact Factor- 6.529). ISSN: 1950-6007*CORRESPONDING AUTHOR

29. Fernandes V, Sharma D, Vaidya S, P A S, Guan Y, Kalia K, Tiwari V* Cellular and molecular mechanisms driving neuropathic pain: recent advancements and challenges. Expert Opinion on Therapeutic Targets 2018 Feb;22(2):131-142. (Impact Factor- 6.902). ISSN: 1744-7631*CORRESPONDING AUTHOR

30. Patel S, Sharma D, Kalia K, Tiwari V*. Crosstalk between Endoplasmic Reticulum Stress and Oxidative Stress in Schizophrenia: The Dawn of New Therapeutic Approaches. Neuroscience and Biobehavioral Reviews 2017 Dec; 83:589-603. (Impact Factor- 8.989). ISSN: 0149-7634*CORRESPONDING AUTHOR

31. Sharma D, Bhattacharya P, Kalia K*, Tiwari V*. Diabetic Nephropathy: New Insights into Established Therapeutic Paradigms and Novel Molecular Targets. Diabetes Research and Clinical Practice 2017 Jun; 128:91-108. (Impact Factor- 5.602) ISSN: 168-8227. *CORRESPONDING AUTHOR

32. Tiwari V, Tiwari V, He SQ, Zhang T, Raja SN, Dong X, Guan Y*. Mas-Related G Protein-Coupled Receptors Offer Potential New Targets for Pain Therapy. Advances in Experimental Medicine and Biology 2016; 904:87-103. (co-first author) (Impact Factor- 2.622) ISSN: 0065-2598.

33. Tiwari V*, Guan Y and Raja SN*. Modulating the Delicate Glial-Neuronal Interactions in Neuropathic Pain: Promises and Potential Caveats. Neuroscience & Biobehavioral Reviews 2014 Sep;45C:19-27. (Impact Factor- 10.284). ISSN: 0149-7634.*CORRESPONDING AUTHOR

34. Chopra K*, Tiwari V. Alcoholic Neuropathy: Possible Mechanisms and Future Treatment Possibilities. British Journal of Clinical Pharmacology 2012 Mar;73(3):348-62  (Impact Factor- 4.335) ISSN: 1365-2125.

35. Chopra K*, Tiwari V. Fetal Alcohol Spectrum Disorders: An Overview of Diverse Mechanisms Involved. Pharmacos 2010; 37:37-43. Chopra K*, Kuhad A, Tiwari V. Rheumatoid Arthritis: A Pathobiological Perspective. Pharmacos 2009; 36:26-31